News
Cigna’s latest SWOT analysis shows a company flexing its market muscles despite tricky healthcare headwinds. Cigna’s strong ...
Supporters say the newly-signed law addresses longstanding concerns about market competition and transparency in the ...
Active large-cap mutual-fund managers have bigger relative positions in financials such as Wells Fargo and BofA than big tech ...
CVS has told Newsweek that some of Arkansas' only 24-hour pharmacies are at-risk of closure because of new state law signed by Republican Governor Sarah Huckabee Sanders last month.
The discussion is almost at a final stage and the company will go to our board, and the board will take a call very soon, ...
Guggenheim has reaffirmed its buy rating on The Cigna Group, setting a target price of $388, making investors grin. The Cigna ...
Explore more
On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE: CI) with a price target of $390.
You probably wouldn’t bet on a horse that usually finishes in the middle of the pack. But, in the stock market, sometimes ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Cigna Healthcare® has sponsored and provided editorial input on this article. Community-focused well-being initiatives are a critical component of the value that hospitals and health systems provide ...
Hims & Hers has delivered strong results and partnerships, but recent Cigna/Novo Nordisk news increases competitive risk and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results